[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Epizyme Inc (EPZM)

Epizyme Inc (EPZM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])

Fundamentals

See More
  • Market Capitalization, $K 247,444
  • Shares Outstanding, K 168,329
  • Annual Sales, $ 37,430 K
  • Annual Income, $ -251,120 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta -0.41
  • Price/Sales 6.70
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -2.15
  • Most Recent Earnings $-0.21 on 08/09/22
  • Next Earnings Date 11/08/22
  • Annual Dividend & Yield (Fwd) 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.4500 +1.38%
on 08/04/22
1.5300 -3.92%
on 08/08/22
unch (unch)
since 07/11/22
3-Month
0.4110 +257.66%
on 06/01/22
1.5800 -6.96%
on 06/27/22
+1.0023 (+214.30%)
since 05/11/22
52-Week
0.4110 +257.66%
on 06/01/22
5.8000 -74.66%
on 09/09/21
-4.0100 (-73.18%)
since 08/11/21

Most Recent Stories

More News
Epizyme Reports Second Quarter 2022 Financial Results and Provides Business Update

Epizyme (Nasdaq: EPZM), a fully integrated, commercial-stage biopharmaceutical company developing and delivering transformative therapies for cancer patients against novel epigenetic targets, today reported...

EPZM : 1.4700 (-1.34%)
Ipsen Extends Expiration Date of Tender Offer for Epizyme, Inc. to 11 August 2022

Regulatory News:

OTC.VN : 0.450 (-2.17%)
IPN : 34.71 (-0.54%)
IPSEY : 44.0700 (-3.70%)
EPZM : 1.4700 (-1.34%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates ONEM, EPZM, LION

/PRNewswire/ -- Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

EPZM : 1.4700 (-1.34%)
LION : 13.62 (-2.44%)
SHAREHOLDER ALERT: Weiss Law Reminds WWE, DRE, MN, and EPZM Shareholders About Its Ongoing Investigations

/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...

MN : 12.85 (+0.16%)
WWE : 100.65 (+2.65%)
DRE : 48.20 (+0.48%)
EPZM : 1.4700 (-1.34%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.